Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.020
-0.060 (-2.88%)
At close: May 29, 2026, 4:00 PM EDT
2.040
+0.020 (0.99%)
After-hours: May 29, 2026, 5:41 PM EDT

Actuate Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
8.1313.168.642.9620.45
Cash & Short-Term Investments
8.1313.168.642.9620.45
Cash Growth
109.13%52.28%192.08%-85.53%-
Other Current Assets
0.390.480.570.040.03
Total Current Assets
8.5213.649.21320.48
Other Long-Term Assets
0.390.390.11--
Total Assets
8.9114.049.32320.48
Accounts Payable
1.21.521.923.422.13
Accrued Expenses
3.494.166.813.52.21
Other Current Liabilities
0.030.030.07--
Total Current Liabilities
4.725.718.86.924.34
Other Long-Term Liabilities
0.40.40.411.521.31
Total Long-Term Liabilities
0.40.40.411.521.31
Total Liabilities
5.136.119.218.445.65
Common Stock
00000
Additional Paid-in Capital
164.02162.53132.485.475.04
Retained Earnings
-160.23-154.61-132.38-105.1-80.35
Total Common Shareholders' Equity
3.787.920.1-99.63-75.31
Minority Interest
---94.1890.14
Shareholders' Equity
3.787.920.1-5.4514.83
Total Liabilities & Equity
8.9114.049.32320.48
Net Cash (Debt)
8.1313.168.642.9620.45
Net Cash Growth
-38.19%52.28%192.08%-85.53%-
Net Cash Per Share
0.370.631.032.0616.89
Book Value
3.787.920.1-99.63-75.31
Book Value Per Share
0.170.380.01-69.43-62.20
Tangible Book Value
3.787.920.1-99.63-75.31
Tangible Book Value Per Share
0.170.380.01-69.43-62.20
SEC Filings: 10-K · 10-Q